Industry News

Texas Tech University opened the $77 million Experimental Sciences Building II in October of 2019 in Lubbock, Texas. Comprising four stories and a basement level, the 117,000-gsf facility provides collaborative environments for interdisciplinary research including four general wet labs, three core instrumentation suites, two synthetic labs, a vivarium, a BSL-2 lab, conference rooms, and offices for researchers and principal investigators.

North Carolina State University broke ground on the $160 million Plant Sciences Building in Raleigh in September of 2019. Designed by Flad Architects, the five-story, 184,000-sf facility will allow academic, government, and industry researchers to develop innovative solutions for global agricultural challenges. Located on the Centennial Campus, the building will house growth chambers, environmental rooms, core instrumentation suites, and labs for genotyping, spectrometry, ag-bio engineering, and chemical and soils analysis.

Pennsylvania State University is planning to construct the $98.5 million Animal, Veterinary and Biomedical Sciences Building in University Park. Designed by HOK, the 105,000-sf facility will provide the College of Agricultural Sciences with research labs, a general-purpose classroom, faculty offices, seminar rooms, and a state-of-the-art vivarium.

The South Dakota Animal Disease Research and Diagnostic Laboratory (ADRDL) celebrated the opening of its expanded Brookings facility in September of 2019. The $58 million project included construction of an 81,000-sf addition offering 3,762 sf of biocontainment space which provides BSL-2E necropsy and BSL-3 facilities. A 4,000-sf chiller plant was also constructed. General contractor McCownGordon broke ground on the expansion in August of 2017. The lab's existing 55,000-sf facility will now undergo renovation and completion is expected in May of 2020.

HALIX is constructing a 72,000-sf cGMP facility at Leiden Bio Science Park in the Netherlands. Utilizing 1000-liter, single-use bioreactors, the five-story building will accommodate the development and manufacture of biopharmaceutical drug substances for clinical and commercial applications. Housing labs for process development, analytical development, and quality control, the structure will feature cleanrooms with unidirectional process flows with separate areas for protein manufacturing and the production of viral vaccines and viral vectors.